Basic Information
LncRNA/CircRNA Name | LINC00958 |
Synonyms | NA |
Region | GRCh38_11:12961842-12989548 |
Ensemble | ENSG00000251381 |
Refseq | NR_038904 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | pancreatic cancer |
ICD-0-3 | C25 |
Methods | qPCR, Western blot, Luciferase reporter assay, RIP, etc. |
Sample | Human PC cell lines PANC-1, Capan-2, SW1990, and BxPC-3 and human normal pancreatic ductal epithelial cell line HPDE |
Expression Pattern | up-regulated |
Function Description | The epithelial mesenchymal transition (EMT) process, cell invasion, and tumor growth were determined in vitro and in vivo. LINC00958 and PAX8 were up-regulated, while miR-330-5p was down-regulated during PC. LINC00958 mainly expressed in the cytoplasm and LINC00958 competitively sponged miR-330-5p. Upregulated miR-330-5p or downregulated PAX8 inhibited the EMT process as well as the invasion and metastasis ability of the PC cells. Moreover, the results indicated that miR-330-5p negatively targeted PAX8, and LINC00958 ultimately showcasing its ability to bind to miR-330-5p through its interaction with AGO2. Therefore, silencing of LINC00958 may bind to miR-330-5p to inhibit PAX8 in a competitive fashion, thereby preventing the progression of PC. |
Pubmed ID | 30639194 |
Year | 2019 |
Title | Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8 |
External Links
Links for LINC00958 | GenBank HGNC NONCODE |
Links for pancreatic cancer | OMIM COSMIC |